MIR4296

Across TCGA pan-cancer cohorts, MIR4296 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MIR4296 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher MIR4296 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR4296 expression acts as an unfavorable survival marker, although some lineages such as OV and SKCM show a favorable association.

LIHC, OV, and UCEC are the cancer types where MIR4296 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	All	0.091	0.559	<.001	48	view →
OV	DFS	Quartile	All	0.612	0.512	.021	24	view →
UCEC	DFS	Tertile	All	0.863	0.904	.011	18	view →
SKCM	OS	Tertile	II,III,IV	0.909	0.722	.023	15	view →
PCPG	OS	Tertile	All	0.916	1.000	.010	9	view →
STAD	OS	Tertile	IV	0.770	0.352	.023	6	view →
LGG	OS	Tertile	All	0.951	0.881	.017	6	view →
PRAD	DFS	Tertile	All	0.970	0.923	.041	6	view →
UCS	OS	Tertile	III,IV	1.000	0.524	.047	6	view →
SARC	OS	Tertile	All	0.262	0.613	.022	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MIR4296–LIHC (DFS)

Open the LIHC breakdown →